Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production.
There is keen interest in the role of the isoprenoids farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP) in protein prenylation and cell function in Alzheimer's disease (AD). We recently reported elevated FPP and GGPP brain levels and increased gene expression of FPP synthase (FPPS) and GGPP synthase (GGPPS) in the frontal cortex of AD patients. Cholesterol levels and gene expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase were similar in AD and control samples, suggesting that homeostasis of FPP and GGPP but not cholesterol is specifically targeted in brain tissue of AD patients (Neurobiol Dis 2009 35:251-257). In the present study, it was determined if cellular levels of FPP, GGPP, and cholesterol affect beta-amyloid (Abeta) abundance in SH-SY5Y cells, expressing human APP695. Cells were treated with different inhibitors of the mevalonate/isoprenoid/cholesterol pathway. FPP, GGPP, cholesterol, and Abeta(1-40) levels were determined, and activities of farnesyltransferase and geranylgeranyltransferase I were measured. Inhibitors of different branches of the mevalonate/isoprenoid/cholesterol pathway as expected reduced cholesterol and isoprenoid levels in neuroblastoma cells. Abeta(1-40) levels were selectively reduced by cholesterol synthesis inhibitors but not by inhibitors of protein isoprenylation, indicating that changes in cholesterol levels per se and not isoprenoid levels account for the observed modifications in Abeta production.
Hooff
Gero P
GP
Department of Pharmacology, Goethe University, Campus Riedberg, Biocenter N260, Max-von-Laue-St. 9, 60438, Frankfurt, Germany.
Peters
Imke
I
Wood
W Gibson
WG
Müller
Walter E
WE
Eckert
Gunter P
GP
D000544:Alzheimer Disease / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism*; D000736:Androstenes; D000818:Animals; D000924:Anticholesteremic Agents / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002460:Cell Line; D002784:Cholesterol / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000378:metabolism; D006801:Humans; D008798:Mevalonic Acid / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism; D011106:Polyisoprenyl Phosphates / Q000378:metabolism*; D012717:Sesquiterpenes / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D000736:Androstenes; D000924:Anticholesteremic Agents; D004791:Enzyme Inhibitors; D010446:Peptide Fragments; D011106:Polyisoprenyl Phosphates; D012717:Sesquiterpenes; C006261:3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one; C004808:farnesyl pyrophosphate; D002784:Cholesterol; C002963:geranylgeranyl pyrophosphate; D008798:Mevalonic Acid
J Biol Chem. 2000 Jan 7;275(1):423-8
10617634
Neurobiol Dis. 2006 May;22(2):209-22
16406223
J Cell Sci. 2007 Jan 15;120(Pt 2):205-12
17215449
Trends Neurosci. 2002 Apr;25(4):191-9
11998687
Clin Biochem. 2007 Jun;40(9-10):575-84
17467679
Brain Pathol. 1999 Jan;9(1):133-46
9989456
Front Biosci. 2008 Jan 01;13:657-76
17981578
Biochim Biophys Acta. 2003 Mar 10;1610(2):281-90
12648781
J Neural Transm Suppl. 1998;54:259-67
9850934
Lipids. 2004 Apr;39(4):293-309
15357017
Cell Mol Life Sci. 2006 Feb;63(3):255-67
16378247
J Neural Transm (Vienna). 2005 Aug;112(8):1057-71
15682268
Neuropathol Appl Neurobiol. 2007 Oct;33(5):523-32
17573808
Anal Biochem. 2005 Jan 1;336(1):51-9
15582558
Physiol Rev. 2001 Jan;81(1):153-208
11152757
J Biol Chem. 2007 Sep 14;282(37):26832-26844
17646164
J Alzheimers Dis. 2005 Apr;7(2):103-17; discussion 173-80
15851848
Nat Med. 2005 May;11(5):545-50
15834426
Cell. 2010 Feb 19;140(4):579-89
20178749
Neurochem Int. 2007 Jul-Sep;51(2-4):92-104
17590478
Int J Mol Med. 1999 Jun;3(6):597-600
10341289
J Biol Chem. 2005 Dec 23;280(51):41793-804
16221687
J Lipid Res. 1980 Jul;21(5):505-17
6995544
Brain Res Mol Brain Res. 2004 Mar 17;122(1):17-23
14992812
Hum Mol Genet. 1999 Jul;8(7):1263-9
10369872
QJM. 2001 Sep;94(9):485-90
11528012
Anal Biochem. 2008 Jul 15;378(2):138-43
18457649
Eur J Biochem. 2001 Sep;268(18):4850-9
11559353
Leuk Res. 2010 Mar;34(3):344-51
19646757
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5815-20
11309494
Biochim Biophys Acta. 2009 May;1788(5):964-72
19366591
Genes Dev. 2005 Jan 1;19(1):1-49
15630019
Neuroreport. 1999 Jun 3;10(8):1699-705
10501560
Anal Bioanal Chem. 2008 Oct;392(4):673-80
18690423
Neurobiol Dis. 2009 Aug;35(2):251-7
19464372
Pharmacopsychiatry. 2003 Sep;36 Suppl 2:S144-8
14574629
J Lipid Res. 1997 Nov;38(11):2216-23
9392419
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5856-61
11296263
J Lipid Res. 2005 May;46(5):904-12
15716592
Traffic. 2001 May;2(5):303-10
11350626
J Biol Chem. 2008 May 16;283(20):14132-43
18347024